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Introduction
This case report describes thrombolysis for axillo-
subclavian vein thrombosis, and discusses causes
and current opinion on management options.
Case report
A 54-year-old architect was admitted with a
one-week history of a painful, swollen right arm.
The patient was otherwise healthy with no signiﬁ-
cant past medical history and, in particular, no
antecedent history of venous thromboembolism
nor of trauma or heavy use of the limb. On exam-
ination, the right arm was grossly swollen, warm
and erythematous with visible distension of the
collateral veins. Ultrasound examination was
performed which demonstrated a thrombus in
the right axillary and subclavian veins.
Following discussion with radiology and vas-
cular teams it was decided to undertake thrombo-
lysis. Venography conﬁrmed occlusion of the right
axillary and subclavian with patency of the bra-
chiocephalic and internal jugular beyond
(Figure 1). A straight multisided catheter was
used to lace the thrombus with approximately
10 mg tissue plasminogen activator (tPA) followed
by an infusion of 0.5 mg/hour along with heparin
via a sheath side arm. No immediate side-effects
were encountered and the patient was transferred
to ITU for monitoring. Follow-up angiography
performed the subsequent day demonstrated
that recanalization of the arm vessels had taken
place and also that there was tight subclavian
vein stenosis which required balloon dilatation.
A radiograph of the cervical spine showed mild
spondylosis but no cervical ribs or elongation to
suggest bands. The patient was discharged home
with a recommendation of at least six months
warfarinization. On review, the patient has experi-
enced no further swelling of the limb which is
functionally normal allowing him to continue in
his career unimpeded.
Discussion
Axillosubclavian vein thrombosis is an uncom-
mon condition accounting for approximately
4% of all deep vein thromboses (DVT).
1 Although
conventionally divided into primary and second-
ary forms, abnormalities such as external com-
pression by a cervical rib or endothelial damage
from strenuous use of the affected limb are
almost always identiﬁed as risk factors in patients
with ‘primary’ axillosubclavian vein thrombosis
where more obvious causative factors, such as
the presence of an indwelling venous catheter,
are lacking. Other risk factors for secondaryaxillo-
subclavian thrombosis include hypercoagulable
states
2 and the presence of cardiac pacemakers.
3
Although historically considered to be a relatively
benign and self-limiting condition, axillosub-
clavian vein thrombosis is now increasingly
recognized as a potential cause of signiﬁcant con-
sequences including pulmonary embolism
4 and
post-thrombotic syndromes.
5
Primary axillosubclavian vein thrombosis
includes Paget-von Schro ¨tter syndrome or
effort-induced thrombosis in which endothelial
damage resulting from strenuous use of the
affected, usually dominant, arm promotes clot for-
mation. Venous compression, caused by a cervical
rib or congenital ﬁbromuscular bands for
example, is also a frequent ﬁnding and thought
to contribute to the formation of the thrombus
resulting in stasis within the affected vein. This
case demonstrates that although commonly
reported in the literature, these risk factors are
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1not universally present and their absence should
not deter consideration of the diagnosis where
examination ﬁndings are suggestive.
Management of axillosubclavian vein thrombo-
sis remains a controversial issue. Earlier conserva-
tive treatment strategies involving rest and
elevation of the limb with anticoagulation have
been associated with high rates of residual
chronic disability
6 and treatment algorithms that
include thrombolysis appear to be associated
with fewer long-term complications.
7 This case
demonstrates successful outcome using local
thrombolysis followed by balloon dilation of sub-
clavian vein stenosis. No anatomical abnormal-
ities of the thoracic outlet were identiﬁed in this
case and, therefore, surgical intervention was not
warranted.
The relative rarity of axillosubclavian vein
thrombosis as opposed to lower limb DVT
means large scale trials are sparse. In addition,
the broad aetiology of the condition means that
extrapolating data from the studies which are
available may not always be relevant, especially in
cases such as this in which classical risk factors
are absent. Studies that have compared the effec-
tiveness of local versus systemic thrombolysis in
lower limb DVT have shown favourable results for
catheter-directed thrombolysis.
8 More large scale
studies covering a wider range of patients are,
however,neededinordertoofferaccurateandcom-
prehensiveadviceonmanagementforpatientswith
axillosubclavian vein thrombosis.
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Figure 1
Venogram of right arm demonstrating occlusion
of right axillary and subclavian veins
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